Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5279825
Max Phase: Preclinical
Molecular Formula: C57H69FN10O10S
Molecular Weight: 1105.30
Associated Items:
ID: ALA5279825
Max Phase: Preclinical
Molecular Formula: C57H69FN10O10S
Molecular Weight: 1105.30
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NCCOCCOCCOCCOCCn2cc(CNc3cccc(Cc4c(C)c5ccc(Oc6ncccn6)cc5oc4=O)c3F)nn2)C(C)(C)C)cc1
Standard InChI: InChI=1S/C57H69FN10O10S/c1-36-45-16-15-44(77-56-60-17-8-18-61-56)31-49(45)78-55(72)46(36)29-41-9-7-10-47(50(41)58)62-32-42-33-67(66-65-42)20-22-74-24-26-76-28-27-75-25-23-73-21-19-59-52(57(4,5)6)54(71)68-34-43(69)30-48(68)53(70)64-37(2)39-11-13-40(14-12-39)51-38(3)63-35-79-51/h7-18,31,33,35,37,43,48,52,59,62,69H,19-30,32,34H2,1-6H3,(H,64,70)/t37-,43+,48-,52+/m0/s1
Standard InChI Key: PNTMCLRWCUWUEW-SMCXORSOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1105.30 | Molecular Weight (Monoisotopic): 1104.4903 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, Yuan L, Xu P.. (2023) Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells., 14 (1.0): [PMID:36655129] [10.1021/acsmedchemlett.2c00446] |
Source(1):